All News #Library
Rare Diseases
CSL Vifor, Travere Therapeutics Acknowledge New KDIGO Guidelines
26 Sep 2025 //
PR NEWSWIRE
England`s NICE Recommends Filspari for IgA Nephropathy
23 May 2025 //
PR NEWSWIRE
CSL Vifor, Travere Therapeutics get EU approval for Filspari
29 Apr 2025 //
PR NEWSWIRE

Market Place
Sourcing Support